94.1% Efficacy Shown in Moderna COVID-19 Vaccine Trial

Results from the primary analysis of the ongoing phase 3 clinical trial demonstrate efficacy in preventing symptomatic COVID-19 infections and severe illness. A peer-reviewed paper...
The post 94.1% Efficacy Shown in Moderna COVID-19 Vaccine Trial appeared first on SciTechDaily.